DocMorris AG (SWX:DOCM)
Switzerland
· Delayed Price · Currency is CHF | Market Cap | 251.02M |
| Revenue (ttm) | 1.06B |
| Net Income (ttm) | -120.87M |
| Shares Out | 48.60M |
| EPS (ttm) | -5.90 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 133,121 |
| Average Volume | 182,851 |
| Open | 5.15 |
| Previous Close | 5.13 |
| Day's Range | 5.10 - 5.23 |
| 52-Week Range | 4.79 - 24.90 |
| Beta | 1.83 |
| RSI | 38.93 |
| Earnings Date | Mar 19, 2026 |
About DocMorris AG
DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. It offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMor... [Read more]
Financial Performance
Financial StatementsNews
DocMorris AG (ZRSEF) Q2 2025 Earnings Call Transcript
DocMorris AG (OTCPK:ZRSEF) Q2 2025 Earnings Conference Call August 19, 2025 5:00 AM ET Company Participants Daniel Wüest - CFO & Member of Executive Board Walter Hess - CEO & Member of Executive Board...
DocMorris AG (ZRSEF) Q4 2024 Earnings Call Transcript
DocMorris AG (OTCPK:ZRSEF) Q4 2024 Earnings Conference Call March 13, 2025 6:00 AM ET Company Participants Walter Hess - Chief Executive Officer Daniel Wüest - Chief Financial Officer Conference Call ...
DocMorris AG (ZRSEF) Q2 2024 Earnings Call Transcript
DocMorris AG (OTCPK:ZRSEF) Q2 2024 Earnings Call Transcript August 20, 2024 5:00 AM ET Company Participants Walter Hess - CEO Marcel Ziwica - CFO Conference Call Participants Urs Kunz - Research Partn...
DocMorris AG (ZRSEF) Q4 2023 Earnings Call Transcript
DocMorris AG (ZRSEF) Q4 2023 Earnings Call Transcript
Online drug retailer DocMorris meets expectations as cost savings help
Swiss online drug retailer DocMorris met expectations on Thursday as it released its full-year results for 2023, helped by structural cost savings.
Online drug retailer DocMorris trims top end of 2023 outlook
Swiss online drug retailer DocMorris on Thursday narrowed down the higher end of its annual core loss forecast, citing weaker development in the paper prescription business.
DocMorris AG (ZRSEF) Q2 2023 Earnings Call Transcript
DocMorris AG (OTCPK:ZRSEF) Q2 2023 Earnings Conference Call August 17, 2023 5:00 AM ET Company Participants Walter Hess - CEO Madhu Nutakki - Chief Technology Officer Marcel Ziwica - CFO Conference Ca...